• Younger people are getting cancer more and more. We have to make kinder medicines

  December 15, 2025 9:28 am

• Top 10 OncoGrants of the Week: Funding Translation, Implementation, and Oncology Capacity

  December 15, 2025 8:25 am

• Summit on Cancer Health Disparities (SCHD26)

  December 15, 2025 5:12 am

• Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress

  December 15, 2025 5:10 am

• The Targeted Pulse: Blood and Breast Cancer News

  December 15, 2025 5:05 am

• APPOS Seattle 2026

  December 15, 2025 5:02 am

• Nadunolimab Misses Efficacy Mark in TNBC, Despite Strong OS

  December 15, 2025 5:01 am

• APPOS Seattle 2026

  December 15, 2025 4:59 am

• Nadunolimab Misses Efficacy Mark in TNBC, Despite Strong OS

  December 15, 2025 4:56 am

• Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress

  December 15, 2025 4:55 am